Safety, PK/PD, and Immunogenicity Study of SC ALXN2030 in Healthy Participants
Clinical trial NCT05501717 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05501717
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-16
- Primary completion
- 2025-10-09
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.